Objectives: To identify the normal baseline preoperative range of cerebral tissue oxygen saturation (SctO 2 ) derived using near-infrared spectroscopy (NIRS) and the efficacy of perioperative interventions designed to modulate SctO 2 in cardiac surgical patients. Design: Systematic review and meta-analysis of relevant randomized controlled trials (RCTs) extracted from the Medline, Embase, and Cochrane Central Register of Controlled Trials databases. Setting: Hospitals performing cardiac surgery. Participants: The study comprised 953 participants from 11 RCTs. Interventions: Interventions included the following: (1) SctO 2 monitoring protocol compared with no monitoring; (2) use of cardiopulmonary bypass (CPB) compared with no CPB; (3) normothermic CPB compared with hypothermic CPB; (4) glyceryl trinitrate during surgery compared with placebo; (5) midazolam during induction of anesthesia compared with propofol; (6) sevoflurane anesthesia compared with total intravenous anesthesia; (7) sevoflurane anesthesia compared with propofol-based anesthesia; and (8) norepinephrine during CPB compared with phenylephrine. Measurements and Main Results: Eleven RCTs with 953 participants measured baseline preoperative SctO 2 using NIRS. The pooled mean baseline SctO 2 was 66.4% (95% CI 65.0-67.7), generating a reference range of 51.0% to 81.8%. Four interventions (1, 3, 4, and 6 described in the Interventions section above) increased intraoperative SctO 2 across the majority of reported time points. Postoperative follow-up of SctO 2 occurred in only 1 study, and postoperative cognitive assessment correlating SctO 2 with cognitive function was applied in only 4 studies using variable methodology. Conclusions: The authors have established that reference values for baseline NIRS-derived SctO 2 in cardiac surgery patients are varied and have identified interventions that modulate SctO 2 . This information opens the door to standardized research and interventional studies in this field.
total hemoglobin in frontal lobe cerebral tissues after subtracting the signal from superficial vessels. 1, 2 This SctO 2 reading principally reflects venous oxygenation, given the proportionally greater volume of the venous system. 3 Thus, NIRS provides potential estimates of the balance between bifrontal oxygen supply and demand. From such information, inferences can be made about global SctO 2 and cerebral oxygenation. Importantly, NIRS differs from pulse oximetry in that it does not limit its signal to that from pulsing blood alone and therefore can be used when there is nonpulsatile cerebral blood flow, as in CPB. 4 Given its potential usefulness, a number of commercial NIRS devices are now available, producing differing results. 5, 6 To date, there has never been a systematic assessment of average values of SctO 2 , the variability of this value, and the associated effect of intraoperative interventions on this value in this cohort of cardiac surgery patients in the literature, despite its potential importance in establishing what is normal. In particular, it may be important to appreciate the relationship, or lack thereof, between intraoperative and postoperative NIRS-derived cerebral oxygen desaturation (COD) and postoperative cognitive dysfunction (POCD).
Accordingly, the authors aimed to identify the normal baseline range of SctO 2 values in cardiac surgical patients, as estimated using NIRS, and the nature and efficacy of interventions seeking to modulate SctO 2 . The authors also aimed to synthesize available data on postoperative SctO 2, mortality, and POCD.
Methods
A protocol for this review was registered prospectively and published as part of the PROSPERO International Prospective Register of Systematic Reviews (CRD42016038410). 7 Medline, Embase, and the Cochrane Central Registry of Controlled Trials were searched through April 15, 2016 for randomized controlled trials (RCTs) that included the evaluation of baseline preoperative SctO 2 with NIRS in adult cardiac surgery patients, using "brain," "oxygenation," and "cardiac surgery" as initial search terms (Appendix 1, Electronic Supplemental Material [ESM] ). RCTs in languages other than English, on children, without baseline NIRS readings reported, without SctO 2 reported as a raw percentage, and published as abstracts without full text were excluded. ClinicalTrials.gov also was searched for current trials underway as of April 15, 2016 , yielding 3 relevant active or recruiting trials. However, data for these trials have not been published and therefore could not be considered for this meta-analysis.
A 2-stage process was used for study selection. Two review authors (M.J.C. and T.C.) independently screened the titles and abstracts of search results and then assessed the eligibility of each full-text trial report using a standardized pre-piloted form outlining the inclusion and exclusion criteria. A third reviewer (N.J.G.) resolved any disagreements. Data collection and bias assessment then were performed by 2 review authors (M.J.C and T.C.) using a pre-piloted form appropriately modified from the Cochrane Collaboration's standardized form as per protocol. 7, 8 The primary outcome measure was baseline preoperative SctO 2 , as measured at any point before induction of anesthesia. Intraoperative SctO 2 , whenever measured between induction of anesthesia and closure of the skin; postoperative SctO 2 , whenever measured between closure of the skin and discharge from hospital; mortality; and POCD as reported in the studies were collected as secondary outcomes. Missing data were entered as reported without imputation.
Measures of central tendency and variance were recorded for continuous variables, with medians and interquartile ranges converted into parametric estimates with the assumption that the distribution of SctO 2 data is similar to a normal distribution. 8 Where multiple values could be compared, pooled measurements of central tendency, standard error, variance, 95% confidence intervals (95% CIs), and theoretical reference ranges (2.5% quantile to 97.5% quantile) then were calculated. Student t-test was used, as appropriate, on parametric continuous variables to calculate and evaluate the effect size of interventions. Publication bias was assessed formally with a funnel plot analysis, and Egger's test was used to test the symmetry of the funnel plot. 9 The Cochran Q statistic and study inconsistency (I 2 , the percentage of total variance across studies attributable to heterogeneity rather than chance) were calculated. They were used to determine heterogeneity of studies in the primary outcome and for each sensitivity analysis, with I 2 ¼ 0% to 40% being no, 40% to 60% being moderate, 60% to 80% being substantial, and 80% to 100% being considerable heterogeneity. 8 Sensitivity analysis included limiting the analysis to measurements of each 
Results
The search strategy identified 601 reports for review: 140 in Medline, 256 in Embase, and 205 in Cochrane Central Registry of Controlled Trials. Of these, 11 RCTs with 953 randomized participants were included in the review (Fig 1) . Characteristics of the included studies are shown in Table 1 . 1, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] There was a wide variation in methodologic quality of the included studies, with only 1 RCT 12 satisfying a low risk of bias in all domains. Five RCTs were deemed to be at particularly high risk of bias (Figs E1 and E2 in Appendix 2 [ESM]).
All baseline preoperative SctO 2 data reported were recorded and used to calculate an overall pooled mean and standard deviation across all 11 RCTs of 66.4% 7 7.8% (standard error 0.65; 95% CI 65.0-67.7) ( Table 2) . A 95% reference range for SctO 2 in cardiac surgical patients was calculated for this figure as 51.0% to 81.8%. Considerable statistical heterogeneity was found among studies, with a Cochran Q statistic of 258.9 (p o 0.001) and an I 2 statistic of 88.8% (Fig 2) . Sensitivity analyses did not demonstrate a significant difference on visual inspection of the data ( 14 with an unreferenced statement of 65% to 75%, and another 17 with figures of 55% to 75% from a reference that actually did not contain such information.
Intraoperative SctO 2 was measured in 7 RCTs, each trialing different interventions (Table 3) . On visual inspection, 4 of these interventions (SctO 2 monitoring protocol compared with no monitoring; normothermic CPB compared with hypothermic CPB; administration of glyceryl trinitrate during surgery compared with placebo; and sevoflurane anesthesia compared with total intravenous anesthesia) had a positive mean effect size of significance in the majority of measured time points. These ranged from a minimum significant effect size of 1.6% (p o 0.001) throughout CPB, with an SctO 2 monitoring protocol in 1 RCT 16 to a maximum significant effect size of 15% (p o 0.001) at the end of CPB on the right hemisphere with glyceryl trinitrate in another. 1 Assessing only the control groups of these studies, intraoperative COD was determined in 8 out of 8 studies (100%) reporting intraoperative SctO 2 or other measures of COD (Table 4) . Only 1 RCT 14 reported postoperative SctO 2 , with no COD determined in either patient group (Table 4) .
Mortality was low in these studies when reported (3 studies), with no intervention demonstrating a statistically significant difference in outcome. POCD also was uncommonly reported (4 studies), with a wide variety of tests and test outcomes being used for assessment (see Table 3 ).
Discussion

Key Findings
The authors conducted a systematic review of all RCTs of interventions measuring and designed to modify NIRS-derived SctO 2 during CPB in adult patients and identified 11 RCTs that reported relevant information. From these studies, the pooled mean baseline preoperative SctO 2 of this clinically heterogenous cohort of cardiac surgical patients was found to be approximately 66%, with a wide reference range. Moreover, the following 4 interventions were observed to possibly improve intraoperative SctO 2 , as supported by 1 RCT each: (1) an SctO 2 monitoring protocol, (2) normothermic CPB compared with hypothermic CPB, (3) glyceryl trinitrate during surgery compared with placebo, and (4) sevoflurane anesthesia compared with total intravenous anesthesia. Finally, follow-up of postoperative SctO 2 , mortality, and POCD was found to be rare among studies involving SctO 2 .
Relationship With Previous Literature
These results were comparable with those reported in a prospective, observational study of 1,178 German adult cardiac surgery patients requiring CPB. 20 In these patients, investigators reported a median baseline SctO 2 on room air of 62% (57%-67%) on the left and 62% (56%-67%) on the right, and a median minimal preoperative oxygen-supplemented SctO 2 of 64% (range: 15%-92%) using the INVOS (Medtronic, Minneapolis, MN) system. Another prospective, observational study of 101 cardiac surgery patients requiring CPB also using the INVOS system found mean baseline SctO 2 values of 58.6% 7 10.2%. 21 These comparatively lower values may be explained by the study protocol, which involved collection of the lower SctO 2 value of the hemispheres for a single reading at each time point.
An early systematic review of the use of NIRS monitoring in cardiac surgery returned only 1 small randomized study and did not discuss baseline preoperative SctO 2 values. 22 A more recent comparison of different NIRS devices in cardiac surgery did not seek to define a normal baseline preoperative SctO 2 range and did not assess the effect of intraoperative interventions on SctO 2 . 23 Even though there were some inconsistencies in the classification of level of evidence compared with the review presented here, there were similar findings regarding the paucity of large randomized research performed in this field, the variety in measurement of POCD, and the predominance of the use of the INVOS system in the literature. Finally, 
Study Implications
The results of the study presented here provided the first RCT-based comprehensive estimate of normal baseline values for SctO 2 in adult cardiac surgery patients, implying that this information likely provided the most robust dataset to date for future comparisons and interventions. Furthermore, these findings suggested that a variety of interventions may increase SctO 2 during CPB significantly, implying that it is possible to manipulate SctO 2 during CPB. However, they also showed that there is almost no knowledge of postoperative changes in SctO 2 and of the link between SctO 2 changes and POCD. It remains possible that this lack of information about postoperative SctO 2 is a major confounder in studies comparing intraoperative COD with POCD, implying that more work is needed to understand these changes and their clinical consequences. This study was not able to provide data comparing different NIRS technologies due to the predominant use of the INVOS system in reviewed studies.
Strengths and Limitations
To the authors' knowledge, this review was the first to metaanalyze and describe baseline SctO 2 in this patient cohort using data from RCTs. The search strategy was systematic and unlikely to introduce bias. It also provided the most up-todate review of the literature on the use of NIRS in cardiac surgery patients. The findings extended the understanding of baseline SctO 2 and trends during cardiac surgery despite the significant clinical and methodologic heterogeneity in the included studies.
However, this review had several limitations. The choice of including only outcome data presented as percentage saturation may have limited the inclusion of some studies with relevant findings; however, this was an unavoidable limitation, given the wide range of definitions in each study for other outcome measures. Only RCTs were considered for inclusion in this review, limiting the pool of studies and patients. However, the authors considered that RCTs would provide the most robust dataset for such assessment. Furthermore, English was a requirement of the search strategy and several studies were excluded on the basis of being published in a non-English language. However, neither of these strategies was likely to add bias to the review. 25 The study findings were limited by the significant clinical heterogeneity and varying methodologic quality of the included studies. This heterogeneity likely was the cause of the funnel plot asymmetry, rather than publication bias, in this setting. In addition, the authors are unable to comment on the potential reasons for the observed wide interindividual variability in baseline SctO 2 due to the limited information available. This lack of information highlights the need for additional study into the effects of patient demographic and physiologic variables on SctO 2 because factors such as patient age, sex, presence of cerebral vascular disease, hemoglobin, and hemodynamic parameters are likely to influence SctO 2 . This study also was not able to provide evidence to suggest that either avoiding intraoperative COD or applying the interventions discussed is beneficial to postoperative patient outcomes.
Conclusions
This systematic review showed that the normal baseline SctO 2 of cardiac surgery patients from 11 identified RCTs was approximately 66%, with a wide reference range. Moreover, this review suggested that intraoperative SctO 2 may be modulated by particular interventions and confirmed there is a paucity of data on postoperative SctO 2 . Finally, the review demonstrated that there is very little or no RCT-derived information on any association between changes in intraoperative or postoperative SctO 2 and POCD. Additional standardized research is indicated to relate intraoperative SctO 2 to normal preoperative values and to identify whether intraoperative and postoperative modulation of SctO 2 is associated with changes in POCD. 
